$SLAB

Silicon Labs (SLAB) Swung to a Non-GAAP Profit, but Wall Street Hesitates

Silicon Labs (SLAB) reported Q2 revenue of $228M, up 18% YoY, and non-GAAP EPS of $0.71, a 545% YoY increase. All segments showed growth, with Medical revenue up 78%. GAAP losses persisted, with an operating loss of $11M. The company is being acquired by Texas Instruments and has suspended guidance. Hedge fund ownership increased slightly, while short interest remains high at 13.68%.

Original reporting
Published Sep 17, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 11:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Silicon Labs (SLAB) Swung to a Non-GAAP Profit, but Wall Street Hesitates — source image
Decision brief

The 30-second read

$SLABNeutralHigh
01

Why it matters

The earnings release provides fresh data on revenue growth and profitability, but the lack of guidance and GAAP loss create uncertainty for price direction.

02

Market read

First‑time earnings disclosure with a profit swing, but pending M&A adds uncertainty; relevant for semiconductor investors.

03

What to watch

Merger‑related costs and large stock‑compensation add‑backs could mask underlying profitability challenges.

Relevance 8/10Novelty 8/10Timing: after‑hours Aug 11 earnings release

Background

Silicon Labs, a wireless chip maker, is in the midst of a pending acquisition by Texas Instruments, which has halted its forward guidance.

Company-level read

Ticker impact

$SLABNeutralHigh confidence
Context

Silicon Labs reported Q2 2026 results with $228M revenue, 18% YoY growth and non‑GAAP EPS of $0.71, swinging to profit.

Expected impact

Potential short‑term upside as investors reassess valuation; however, high short interest and GAAP loss may cap gains.

Evidence & confidence

The surprise shift to non‑GAAP profit provides a fresh catalyst, but uncertainty around the TI deal and lack of guidance limit conviction.

Market effects

Positive signal for the broader semiconductor and IoT chip sector as demand accelerates across industrial, commercial, and medical segments.

U.S. semiconductor stocks may see modest buying pressure; Texas Instruments acquisition adds strategic interest.

Highlights continued growth in global chip demand, potentially influencing supply‑chain outlook worldwide.

Counterpoint

Investors may short SLAB anticipating that GAAP losses and high valuation outweigh the non‑GAAP profit boost.

Key entities

  • Silicon Labs

    Wireless chip maker reporting Q2 results.

  • Texas Instruments

    Acquirer of Silicon Labs, influencing merger‑related costs.

Related articles

$TXNHighAI 8/10

Texas Instruments Prices $2 Billion Debt to Fund Silicon Labs Ac

Texas Instruments (TXN) priced $2B in senior unsecured notes to fund its acquisition of Silicon Labs (SLAB). The debt has four tranches maturing between 2028 and 2036 with interest rates from 5.000% to 5.750%. TXN offers a 2.04% dividend yield, a 73% payout ratio, and a 5.5% 3-year dividend growth rate. The company's GF Value suggests it is 20.5% overvalued, with a strong GF Score of 85/100.

$TXNMedAI 8/10

Texas Instruments notes sale raises $2bn for Silicon Labs deal

Texas Instruments (TXN) raised $2.0 billion via a notes sale to fund its $7.5 billion acquisition of Silicon Laboratories. The debt is split into four tranches with maturities ranging from 2028 to 2036, with coupon rates between 5.000% and 5.750%. The company's strong credit ratings and recent revenue growth support the financing. TI shares closed at $299.50 on 26 October, up 2.7% on the day.